Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cationic lipid-mediated gene transfer: current concepts.

P R Clark1, E M Hersh

  • 1Arizona Cancer Center, University of Arizona, Tucson 85724, USA. prc@u.arizona.edu

Current Opinion in Molecular Therapeutics
|November 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facial expressivity in dominant macaques is linked to group cohesion.

Proceedings. Biological sciences·2024
Same author

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

A magnetic resonance imaging based method for measurement of tissue iron concentration in liver arterially embolized with ferrimagnetic particles designed for magnetic hyperthermia treatment of tumors.

Magnetic resonance imaging·2003
Same author

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.

Cancer immunology, immunotherapy : CII·2001
Same author

The inducible Hsp70 as a marker of tumor immunogenicity.

Cell stress & chaperones·2001
Same author

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Gene therapy using cationic lipoplexes offers a promising approach for treating various diseases. Research focuses on optimizing gene transfer into somatic cells for safer and more effective treatments, particularly for cancer.

Area of Science:

  • Biotechnology and Gene Therapy
  • Molecular and Cellular Biology
  • Biomedical Engineering

Background:

  • Gene therapy and gene transfer strategies hold potential for treating diverse conditions including infectious diseases, heart disease, cancer, and genetic defects.
  • The efficacy of gene therapy is contingent upon precise control and manipulation of gene transfer into somatic cells.
  • Current gene transfer methods utilize viral or non-viral approaches, with ongoing research to identify optimal systems for safe and reliable delivery.

Purpose of the Study:

  • To review recent advancements in cationic lipid-mediated gene transfer, focusing on in vivo applications.
  • To discuss molecular and cellular factors influencing the uptake, transit, and expression of cationic lipoplexes in somatic cells.
  • To examine biodistribution, pharmacokinetics, toxicity, and immunogenicity of cationic lipoplexes, alongside clinical trial outcomes, especially in cancer.

Related Experiment Videos

Main Methods:

  • Review of recent scientific literature on cationic lipid-mediated gene transfer.
  • Analysis of studies focusing on molecular and cellular mechanisms of lipoplex interaction with somatic cells.
  • Survey of preclinical and clinical trial data, including biodistribution, pharmacokinetic, toxicity, and immunogenicity assessments.

Main Results:

  • Cationic lipoplexes are a popular non-viral gene transfer method due to ease of production, low toxicity, and capacity for large polynucleotide delivery.
  • Significant progress has been made in understanding the factors governing cationic lipid-mediated gene transfer efficiency and safety.
  • Ongoing research and clinical trials are exploring the therapeutic potential of cationic lipoplexes, particularly for cancer treatment.

Conclusions:

  • Cationic lipid-mediated gene transfer is a rapidly advancing field with substantial potential for therapeutic applications.
  • Further research into molecular and cellular events is crucial for optimizing lipoplex-based gene delivery systems.
  • Continued investigation into safety, efficacy, and clinical outcomes is essential for the successful translation of gene therapy strategies.